West Virginia patients are left in limbo over changing insurance coverage of obesity medications
1 week ago

West Virginia patients are left in limbo over changing insurance coverage of obesity medications

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Citing a gross cost of $1.4 million a month, West Virginia abruptly announced in March it would indefinitely pause a pilot program covering weight loss drugs for 1,000 public employees, leaving patients like her scrambling. West Virginia’s Public Employee Insurance Agency will continue covering the popular and expensive GLP-1 drugs to treat Type 2 diabetes. Dr. Laura Davisson, medical weight management director at West Virginia University, said losing coverage for medications is a “nightmare” for patients. PEIA Director Brian Cunningham said GLP-1s, which the state began offering for weight loss in 2019, cost the program around $53 million last fiscal year — about 20% of what PEIA spends on drugs.

History of this topic

West Virginia patients are left in limbo over changing insurance coverage of obesity medications
1 week ago

Discover Related